Literature DB >> 19807278

Disparity in the in vitro versus in vivo regulation of fibronectin-binding proteins by 2 global regulators, saeRS and sigB, in Staphylococcus aureus.

Ambrose L Cheung1, Soo-Jin Yang, Arnold S Bayer, Yan Q Xiong.   

Abstract

Fibronectin-binding protein A plays an important role in Staphylococcus aureus endovascular infections. We characterized the sigB-saeRS-fnbA expression network with fibronectin binding in vitro and in an experimental infective endocarditis (IE) model using parental strains RN6390 and SH1000 and their respective isogenic saeRS mutants. In contrast to the in vitro data, there was no influence of saeRS on fnbA expression in the IE model, yet ex vivo fibronectin binding was reduced in saeRS mutants. Moreover, as opposed to the in vitro findings, sigB appeared to have a positive rather than a negative effect on saeRS expression within cardiac vegetations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19807278      PMCID: PMC2814518          DOI: 10.1086/606011

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Influence of a functional sigB operon on the global regulators sar and agr in Staphylococcus aureus.

Authors:  M Bischoff; J M Entenza; P Giachino
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

Review 2.  Pathogenesis of streptococcal and staphylococcal endocarditis.

Authors:  Philippe Moreillon; Yok A Que; Arnold S Bayer
Journal:  Infect Dis Clin North Am       Date:  2002-06       Impact factor: 5.982

3.  Reassessing the role of Staphylococcus aureus clumping factor and fibronectin-binding protein by expression in Lactococcus lactis.

Authors:  Y A Que; P François; J A Haefliger; J M Entenza; P Vaudaux; P Moreillon
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

4.  Identification and characterization of a novel 38.5-kilodalton cell surface protein of Staphylococcus aureus with extended-spectrum binding activity for extracellular matrix and plasma proteins.

Authors:  M Hussain; K Becker; C von Eiff; J Schrenzel; G Peters; M Herrmann
Journal:  J Bacteriol       Date:  2001-12       Impact factor: 3.490

5.  Strain-dependent differences in the regulatory roles of sarA and agr in Staphylococcus aureus.

Authors:  Jon S Blevins; Karen E Beenken; Mohamed O Elasri; Barry K Hurlburt; Mark S Smeltzer
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

6.  Analysis of Ebh, a 1.1-megadalton cell wall-associated fibronectin-binding protein of Staphylococcus aureus.

Authors:  Simon R Clarke; Llinos G Harris; R Geoff Richards; Simon J Foster
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

7.  Regulation of Staphylococcus aureus type 5 capsular polysaccharides by agr and sarA in vitro and in an experimental endocarditis model.

Authors:  Willem van Wamel; Yan-Qiong Xiong; Arnold S Bayer; Michael R Yeaman; Cynthia C Nast; Ambrose L Cheung
Journal:  Microb Pathog       Date:  2002-08       Impact factor: 3.738

8.  Activation and transcriptional interaction between agr RNAII and RNAIII in Staphylococcus aureus in vitro and in an experimental endocarditis model.

Authors:  Yan-Qiong Xiong; William Van Wamel; Cynthia C Nast; Michael R Yeaman; Ambrose L Cheung; Arnold S Bayer
Journal:  J Infect Dis       Date:  2002-08-09       Impact factor: 5.226

9.  The staphylococcal saeRS system coordinates environmental signals with agr quorum sensing.

Authors:  Richard P Novick; Dunrong Jiang
Journal:  Microbiology       Date:  2003-10       Impact factor: 2.777

10.  Impacts of sarA and agr in Staphylococcus aureus strain Newman on fibronectin-binding protein A gene expression and fibronectin adherence capacity in vitro and in experimental infective endocarditis.

Authors:  Yan-Qiong Xiong; Arnold S Bayer; Michael R Yeaman; Willem Van Wamel; Adhar C Manna; Ambrose L Cheung
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

View more
  5 in total

1.  Role of fibronectin-binding proteins A and B in in vitro cellular infections and in vivo septic infections by Staphylococcus aureus.

Authors:  Hitomi Shinji; Yukio Yosizawa; Akiko Tajima; Tadayuki Iwase; Shinya Sugimoto; Keiko Seki; Yoshimitsu Mizunoe
Journal:  Infect Immun       Date:  2011-03-21       Impact factor: 3.441

2.  Natural variability of in vitro adherence to fibrinogen and fibronectin does not correlate with in vivo infectivity of Staphylococcus aureus.

Authors:  Mathilde Ythier; Jose M Entenza; Jacques Bille; François Vandenesch; Michèle Bes; Philippe Moreillon; Olga Sakwinska
Journal:  Infect Immun       Date:  2010-01-11       Impact factor: 3.441

3.  Exploring the transcriptome of Staphylococcus aureus in its natural niche.

Authors:  Diego Chaves-Moreno; Melissa L Wos-Oxley; Ruy Jáuregui; Eva Medina; Andrew Pa Oxley; Dietmar H Pieper
Journal:  Sci Rep       Date:  2016-09-19       Impact factor: 4.379

4.  Differential effects of Hsp90 inhibition on corneal cells in vitro and in vivo.

Authors:  VijayKrishna Raghunathan; Sydney Garrison Edwards; Brian C Leonard; Soohyun Kim; Alexander T Evashenk; Yeonju Song; Eva Rewinski; Ariana Marangakis Price; Alyssa Hoehn; Connor Chang; Christopher M Reilly; Santoshi Muppala; Christopher J Murphy; Sara M Thomasy
Journal:  Exp Eye Res       Date:  2020-11-18       Impact factor: 3.467

5.  Molecular epidemiology and expression of capsular polysaccharides in Staphylococcus aureus clinical isolates in the United States.

Authors:  Naglaa Mohamed; Yekaterina Timofeyeva; Dorota Jamrozy; Eduardo Rojas; Li Hao; Natalie C Silmon de Monerri; Julio Hawkins; Guy Singh; Bing Cai; Paul Liberator; Shite Sebastian; Robert G K Donald; Ingrid L Scully; C Hal Jones; C Buddy Creech; Isaac Thomsen; Julian Parkhill; Sharon J Peacock; Kathrin U Jansen; Matthew T G Holden; Annaliesa S Anderson
Journal:  PLoS One       Date:  2019-01-14       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.